A new orally administered norovirus vaccine tablet has demonstrated promising safety and immunogenicity in older adults.
That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback